Diagnostic and Interventional Cardiology

News | Hemostasis Management

Teleflex Acquires Hemostatic Products Vendor Z-Medica

February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading ...

February 08, 2021

Videos | Cath Lab

VIDEO: Patients Fear COVID More than Heart Attacks

Cindy Grines, M.D., MSCAI, FACC, president of the Society for Cardiovascular Angiography and Interventions (SCAI), and ...

February 04, 2021

Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session.

News | Heart Valve Technology

Bicuspid Aortic TAVR May Create Huge Market For Transcatheter Valves

February 4, 2021 — Transcatheter aortic valve replacement (TAVR) has historically only been used with caution in the ...

February 04, 2021

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies.

News | Cardiovascular Business

Modern Vascular Opens New Outpatient Cath Lab to Treat Peripheral Artery Disease

February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat peripheral artery ...

February 03, 2021

Figure 1: Picture of the Emblem S-ICD Subcutaneous Electrode with an arrow showing where separation usually happens (distal to the proximal sense ring).

Feature | Implantable Cardioverter Defibrillator (ICD) | By Dave Fornell, Editor

Boston Scientific Recalls Emblem S-ICD After 26 Serious Injuries and One Death

February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific ...

February 02, 2021

The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location.

News | EP Lab

Patient Data From Several Cardiac Devices Streamlined Into One Platform With New Cloud-based Software

February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current ...

February 02, 2021

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.

News | ECG

Cardiac Insight Speaks Out Against Medicare Decision to Slash Reimbursement Rates and Limit Access to New ECG Technologies

February 2, 2021 — Cardiac Insight, Inc. a healthcare company specializing in wearable cardiac sensors and automated ...

February 02, 2021

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

News | Cardiac Diagnostics

Link Shown Between Economic Disparities and Cardiovascular Death in Middle-Aged Adults

February 2, 2021 — A new study has found in the U.S. shows higher economic prosperity was associated with a small ...

February 02, 2021

The most popular story in the month of January 2021 was on a small study that showed the new iPhone 12 can cause ICDs to stop functioning. COVID-19 content continues to rank among the top stories, including an article on the possible long-term cardiac consequences of COVID-19 infection in COVID long-haulers.

Feature | By Dave Fornell, Editor

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

February 01, 2021

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

Medtronic's DiamondTemp Ablation (DTA) system is FDA cleared to treat patients with recurrent, symptomatic paroxysmal atrial fibrillation (AF) and who have been unresponsive to drug therapy. The DiamondTemp system is the first FDA-approved, temperature-controlled, irrigated radiofrequency (RF) ablation system with diamonds currently available to deliver ablations.

News | Atrial Fibrillation

FDA Clears Medtronic DiamondTemp Ablation System to Treat Atrial Fibrillation

January 29, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Medtronic's DiamondTemp Ablation (DTA) system ...

January 29, 2021

News

North American Medical Devices Deals Drops in late 2020

January 29, 2020 — North America’s medical devices industry saw a drop of 17.3% in overall deal activity during the ...

January 29, 2021

Patients with atrial fibrillation are at far greater risk of a catastrophic COVID outcomes, so steps should be taken to reduce AFib risks in addition to precautions against COVID like making, hand washing and social distancing. Images include an electromap from an AF ablation procedure and a COVID-19 from the CDC.

Feature | Atrial Fibrillation | By John D. Day, M.D., T. Jared Bunch, M.D., and Matthew D. LaPlante

Addressing Atrial Fibrillation in the World of COVID-19

In our most challenging and distressing days, it is nice to think about a post-COVID-19 world. But while this pandemic ...

January 27, 2021

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

The Philips AAA Model integrates software and Philips 3-D ultrasound technologies into a single solution to automatically segment and quantify the size of the aneurysm sac for surveillance of known native and post-EVAR treated AAAs.

News | Cardiovascular Ultrasound

Philips 3-D Ultrasound Offers New Surveillance Method for Abdominal Aortic Aneurysms

January 27, 2021 — Philips Healthcare has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing ...

January 27, 2021

Heavily calcified coronary arteries seen on a CT scan of the heart. Research at the New York Institute of Technology will create blood flow modeling to show the impact of calcium in arteries as part of a project to develop treatments to remove calcium.

News | Cardiovascular Clinical Studies

Vascular Decalcification as Heart Disease Treatment Examined in $1.8 Million NIH Grant

January 27, 2021 — A New York Institute of Technology research team has secured a five-year $1.8 million grant from the ...

January 27, 2021

The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.

News | Heart Failure

Occlutech's Atrial Flow Regulator for Heart Failure Receives FDA Breakthrough Device Designation

January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation ...

January 27, 2021